<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: significantly increased</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Widely used cancer drug associated with significantly increased risk of blood clots</title>
   	 <description>An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs), according to an article in the November 19 issue of JAMA.</description>
     <link>http://www.physorg.com/news146247931.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 18 Nov 2008 16:25:31 EST</pubDate>
	 <guid isPermaLink="false">news146247931</guid>
</item>


</channel>
</rss>

